#27 of 500 · Foundation / Grantmaker / DAF
Bristol-Myers Squibb Patient Assistance Foundation Inc
A not-for-profit, company-sponsored operating foundation established in 1999 and based in New Jersey. It provides Bristol Myers Squibb prescription medicines free of charge to eligible patients experiencing financial hardship who have no prescription drug insurance and do not qualify for Medicaid or other government drug programs. It offers temporary assistance to help patients access needed medications.
Open the interactive profileFinancials, fiscal 2023
- Revenue
- $4.45B
- Expenses
- $4.46B
- Total assets
- $232.0M
- Net assets
- $221.3M
- Operating margin
- -0.2%
- 1-year growth
- 46.8%
- 5-year growth (CAGR)
- 35.5%
- Reserve (years of spending)
- 0.6
- Contributions share
- 100.0%
- Programme spending
- n/a
- Fundraising cost
- n/a
- Executive pay share
- 0.00%
- Employees
- n/a
- Revenue per employee
- n/a
- Grants paid
- n/a
- Years filing
- 24
NFP Health Score: 61 / 100
Financial 34 · Governance 85 · Operational 90. The score is built from Form 990 line items only. It cannot measure how well an organisation delivers its mission.
Mission
To provide certain Bristol Myers Squibb medicines free of charge to eligible patients who are experiencing financial hardship and who have no prescription drug coverage.
Revenue history
| Year | Revenue |
|---|---|
| 2019 | $1.32B |
| 2020 | $1.58B |
| 2021 | $1.80B |
| 2022 | $3.04B |
| 2023 | $4.45B |